Physician profile
David F Klein
NPI 1336327428
$2,200.03
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,751 · 2020: $58.64 · 2021: $271 · 2022: $119.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,786.63 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $104.92 | 2019 | |
| Merz North America, INC. | $93.28 | 2019 | |
| Sientra, INC. | $72.04 | 2019-2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $52.53 | 2019 | |
| Mentor Worldwide LLC | $46.21 | 2019 | |
| Galderma Laboratories, L.P. | $28.15 | 2021-2022 | |
| Acelrx Pharmaceuticals, INC. | $16.27 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.